"Substantial" increases in list and net prices of branded drugs in the US Clinical study 21 March 2020 Pages: 2 - 2
Apremilast less costly in biologic-naïve patients with psoriatic arthritis Clinical study 21 March 2020 Pages: 3 - 3
Burden of spinal muscular atrophy substantial in Catalonia, Spain Clinical study 21 March 2020 Pages: 4 - 4
Cost effectiveness of step therapy in T2DM depends on payer perspective Clinical study 21 March 2020 Pages: 6 - 6
Direct non-medical/indirect costs of T2DM substantial in Vietnam Clinical study 21 March 2020 Pages: 7 - 7
Emtricitabine/tenofovir alafenamide not cost effective despite fewer AEs Clinical study 21 March 2020 Pages: 8 - 8
Granulomatosis with polyangiitis substantial economic burden in the US Clinical study 21 March 2020 Pages: 9 - 9
HCCI publishes Health Care Cost and Utilization report for 2014−2018 News item 21 March 2020 Pages: 11 - 11
Healthcare costs lower with treprostinil versus selexipag for PAH Clinical study 21 March 2020 Pages: 12 - 12
Hippocampal avoidant whole brain radiotherapy cost effective Clinical study 21 March 2020 Pages: 13 - 13
Influenza vaccine "unlikely" to be cost effective for high-risk children in The Netherlands Clinical study 21 March 2020 Pages: 15 - 15
Is HIV PrEP for heterosexual men cost effective in South Africa? Clinical study 21 March 2020 Pages: 16 - 16
LAI antipsychotics may reduce costs and hospitalisations in Germany Clinical study 21 March 2020 Pages: 18 - 18
Lobbying expenditure and campaign contributions by US health industry Unknown 21 March 2020 Pages: 19 - 19
Oromucosal cannabinoid for MS spasticity: benefits at acceptable cost Clinical study 21 March 2020 Pages: 21 - 21
Pharmacist-led intervention cost effective for reducing NSAID use in older Canadians Clinical study 21 March 2020 Pages: 22 - 22
R&D costs for new therapeutic agents estimated at mean $US1.3 billion Non-clinical study 21 March 2020 Pages: 23 - 23
Reduced utilisation and costs with enzalutamide vs abiraterone in prostate cancer Clinical study 21 March 2020 Pages: 24 - 24
Repeat streptococcal B screening cost effective in pregnant women Clinical study 21 March 2020 Pages: 25 - 25
Risk-based obstetric care improves perinatal outcomes, reduces costs Clinical study 21 March 2020 Pages: 26 - 26
Safety, efficacy and total costs of multiple myeloma regimens Clinical study 21 March 2020 Pages: 27 - 27
Telephonic diabetes self-management intervention reduces hospital costs Clinical study 21 March 2020 Pages: 28 - 28
Telotristat ethyl "affordable" addition to standard carcinoid syndrome care in Sweden Clinical study 21 March 2020 Pages: 29 - 29
Variance in cost accrual rates over time for AML patients in the US Clinical study 21 March 2020 Pages: 31 - 31
Varying cost effectiveness of pre-travel Japanese encephalitis vaccination in US Clinical study 21 March 2020 Pages: 32 - 32
UK NICE recommends fremanezumab for chronic migraine prevention News item 21 March 2020 Pages: 37 - 37